King Charles has officially stripped the former Duke of York, now Andrew Mountbatten Windsor, of his HRH style and his prince title.
Charles formally made the changes, which were announced a week ago, by issuing a letters patent under the great…

King Charles has officially stripped the former Duke of York, now Andrew Mountbatten Windsor, of his HRH style and his prince title.
Charles formally made the changes, which were announced a week ago, by issuing a letters patent under the great…

Manchester United head coach Ruben Amorim has admitted the club has made mistakes – but stressed they must look to the future rather than dwell on the past.
In an extensive interview with Piers Morgan earlier this week, legendary former United…

Available for over a year
Alison Mitchell, Jim Maxwell and Charu Sharma are celebrating India women’s first ever World Cup victory! Former India women’s captain Anjum Chopra tells us how she felt at the winning moment, what it was like to be…

Diaphragmatic eventration (DE) is a rare disease, with an estimated incidence of 1 in 10,000.1 It is a condition in which the diaphragm becomes abnormally thinner and looser than normal and bulges owing to congenital developmental…


EXCLUSIVE: Here’s a first look at Emilia Clarke (Game Of Thrones) and Edgar Ramírez (Emilia Perez) in romantic comedy-drama Next Life, written and directed by Drake Doremus (Like Crazy). Jack Farthing (Spencer) also stars.
Continue Reading

A&O Shearman is pleased to announce its role advising TT Electronics plc (TT) on the recommended cash and share offer from Cicor Technologies Ltd. (Cicor).
TT is listed on the main market of the London Stock Exchange and is a global provider of engineered electronics for performance critical applications. TT serves market-leading customers across healthcare, aerospace and defense, and automation and electrification end markets, providing engineering and manufacturing solutions. Its portfolio of products includes power management devices, sensors, and connectivity solutions, with products designed and manufactured for harsh environments and regulated sectors.
Cicor is a globally active provider of full-cycle electronic solutions, from research and development to manufacturing and supply chain management, serving businesses in the healthcare and medical, industrial, and aerospace and defense industries. Cicor’s shares are listed on the SIX Swiss Exchange.
The transaction values TT at GBP287m and is expected to complete in the first half of 2026, subject to customary regulatory conditions and approval from TT’s shareholders.
The transaction marks the latest chapter in A&O Shearman’s long-standing relationship with TT, which has included advising TT on the disposal of its Transportation Sensing and Control division and on its public takeover of UK-listed Stadium Group plc.
Annabelle Croker, M&A partner at A&O Shearman, said: “The acquisition represents a compelling strategic proposition for TT’s stakeholders, bringing together two highly reputable and complementary brands in the Electronics Manufacturing Services sector. The transaction delivers accelerated value for TT’s shareholders, whilst retaining the ability for them to benefit from potential synergies and future upside from continued ownership in the combined business. Our team has worked closely with TT for many years, and we are delighted to be supporting them on this transaction.”
The A&O Shearman team was led by London M&A partners Annabelle Croker and Matt Hamilton-Foyn, with support from senior associates Anthony Bowen and Gina Malone, associates Maryam Usman, Charles Ashie, and Lewis Devonald, and trainees James Dickinson, Yasmine Chbary, and Callum Donnelly. Incentives advice is being provided by partner Mahesh Varia and associate Betty Lorimer. Antitrust and FDI advice is being provided by partner Tom Masterman and associate Alexander Westin-Hardy. Tax advice is being provided by partner Tim Harrop and associate Maria Clezy.

A study published in Scientific Reports, has identified specific microRNA (miRNA) expression patterns that could serve as valuable diagnostic and prognostic biomarkers for endometrioid endometrial cancer (EEC), the most common subtype of…